Cargando…
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
BACKGROUND: There are a lot of unmet needs in patients with triple-negative breast cancer (TNBC). Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPAR-α) agonist, has been used for decades to treat hypertriglyceridaemia and mixed dyslipidaemia. Recent studies show that it might have...
Autores principales: | Li, Ting, Zhang, Qunling, Zhang, Jian, Yang, Gong, Shao, Zhimin, Luo, Jianmin, Fan, Minhao, Ni, Chen, Wu, Zhenhua, Hu, Xichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015735/ https://www.ncbi.nlm.nih.gov/pubmed/24529079 http://dx.doi.org/10.1186/1471-2407-14-96 |
Ejemplares similares
-
Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy
por: Zhang, Jian, et al.
Publicado: (2015) -
Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT/NF-κB pathway
por: Sun, Jianguo, et al.
Publicado: (2019) -
NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
por: Han, Dongfeng, et al.
Publicado: (2015) -
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer
por: Song, Linjiang, et al.
Publicado: (2020) -
Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
por: Shi, Xiaoyu, et al.
Publicado: (2023)